Blog posts

Articles, Blog posts

What Do Psychiatrists Think of Women?

What Do Psychiatrists Think of Women? March 13, 2026 – Robert Carter Not much, it seems. For years women were not even used as subjects in clinical trials for new psychiatric drugs because their monthly periods might have skewed their results compared to male subjects. The FDA had issued a 1977 guideline that barred women of reproductive potential from participating in early-phase clinical trials. Finally, in 1993, the National Institute of Health Revitalization Act required the inclusion of women in any NIH research. Male bodies had been the “norm.” Women’s were not. Psychiatry had reworked mental illness to be seen as a medical, not a psychological problem, in order to raise psychiatrists to the authority and prestige level of medical doctors…and above the popular moniker of “quack” which had become so prevalent during the nineteen-fifties. The use of “hysteria” – the Greek word for uterus — had been dropped from the DSM in 1980, but was replaced with “histrionic disorder.” Both terms, of course, described female, not male, conditions. Finally, in 2013, “premenstrual dysphoric disorder” was added to the DSM as a mental disorder…also unique to women, of course. Two thirds of all psychiatrists are men. Male psychiatrists also comprise most of the higher authority roles in the field. Only 22 percent of college psychiatry department chairs, for instance, are women – half of what it should be proportionately. More than three-quarters of the psychiatrists who prescribe and perform electroshock therapy are male, but two-thirds of the patients who receive electroshock therapy are women. A 1994 study showed that women are three times more likely to be prescribed psychotropic drugs than men for the exact same symptoms. It is estimated that in America male psychiatrists have sexually abused 150,000 of their female patients. 21,000 of these women have tried to commit suicide. 16,000 of them have ended up hospitalized because of the sexual violation by a male psychiatrist. 21,000 of them have tried to commit suicide. 1500 have succeeded. What psychiatrist came up with the bright idea to run 460 volts through a human brain as a “therapy”? A male psychiatrist. What psychiatrist came up with the bright idea to lobotomize a patent – like Rose Kennedy – and physically remove part of her brain as a therapy? A male psychiatrist. Which gender is the one most damaged by these vicious practices? Ladies, it’s you. So…what do psychiatrists think of women?

Articles, Blog posts

How Brainwashed Are We by Big Pharma?

How Brainwashed Are We by Big Pharma? March 5, 2026 – Robert Carter You know you’re about to be taken for a ride into the clutches of Big Pharma when you read the headline of an Associated Press article published this week: Top FDA drug official is trying to hire a friend who’s seeking a bold new warning on antidepressants. Despite the Associated Press declaration that it is an unbiased, independent, non-profit news cooperative, this headline immediately denigrates FDA drug regulator, Dr. Tracy Beth Hoeg, before we even learn any facts of the case. Suggesting she’s hiring someone because he’s a friend, not because he’s a competent clinician, is an attempt to bias us against the good doctor even before we read this “news.” In fact, Dr. Adam Urato – the “friend” in question – is a maternal-fetal medical specialist with a substantial track record of accomplishments. Why are he and Dr. Hoeg being so targeted? Because both these high ranked doctors believe that, given the recent clinical evidence, antidepressants might adversely affect pregnant women and their fetuses. Therefore, a stronger Black Box warning about those risks should be printed on bottles of Prozac, Paxil, Zoloft, and other comparable generic antidepressants. “I think women should be informed about the potential risks so that they have time to come off SSRIs if they want to when they’re trying to get pregnant,” Dr. Hoeg told the hosts of a recent Mom Wars podcast. Sounds pretty sensible, right? After all, fifteen percent of American women take antidepressants. But it’s not sensible if you’re Big Pharma and you worry that your astronomical drug profits will be cut into by unruly, pregnant women deciding to cancel their prescriptions for antidepressants. The Associated Press article then quotes psychiatrist Dr. Jennifer Payne, a University of Virginia reproductive psychiatrist, as their “authority.” “A black box warning is a big red flag with both practitioners and patients,” she says. “What’s missing in this petition is an understanding of the risks of maternal mental illness during pregnancy.” Oh, yes. There are far too many women – pregnant or not — suffering out there from mental illness. Let’s not make them afraid to take an antidepressant. It’s their only lifeline to mental health. This is the standard Big Pharma party line: Because there are so many people out there suffering from mental illness – and who knows how many more we haven’t even diagnosed yet, they say – we can’t deprive these poor souls of their psychotropic meds just because a few alarmist critics are trying to alert us to the dangers of our psychotropic drugs. So Big Pharma spokesperson Dr. Payne’s proclamation is hardly unexpected. She’s a psychiatrist, after all. (By the way, what in the world is a “reproductive psychiatrist”?) What should be unexpected is the Associated Press putting out such a covert hit piece on Drs. Hoeg and Urato. The article cites none of the recent studies that do suggest actual dangers to pregnant women from antidepressants. And there’s no factual content about Dr. Hoeg doing anything to “hire” Dr. Urato, other than using him, appropriately, as a a pregnancy expert consultant. It is true that they are long term associates — hardly surprising seeing they work in the same medical specialty field — and, as Dr. Urato says, they’ve become friendly over their years working together, just as many other of his associates have become “friends,” as well. That’s hardly uncommon in such situations. So why such a hit piece? Is it because Big Pharma is secretly funding AP? Apparently not, per the financial records publicly available. AP is exceptionally clean financially and does not accept any of Big Phrama’s $7 billion advertising payments to other media outlets. No, unfortunately this “hit piece” is due only to the long term brainwashing by Big Pharma of the conventional American mind. This is how too many people think these days, even those at news agencies like AP with a decent reputation for objectivity. Since the 1980s their coverage of medicine and health policy and has become so indoctrinated by pro-Big Pharma think – just like so many other Americans – that they don’t recognize when they have strayed so far from journalistic objectivity. If you can only think with Big Pharma’s implanted foundation of pro-psychiatry gobbledy- gook, you’re no longer going to be able to see what is actually out there.

Articles, Blog posts

Psychiatry’s “Adjustment” Is No Ideal for Mental Health

Psychiatry’s “Adjustment” Is No Ideal for Mental Health February 24, 2026 – Robert Carter Bruce Levine published a poignantly thoughtful article this week on Mad in America in which he challenges the conventional psychiatric idea of what constitutes mental health. He points out that the idea of adjustment by a person to his or her personal, institutional, and environmental surroundings is part and parcel of their notion of mental health. Levine brightly notes that adjustment to an insane world and taking on its attributes is hardly a satisfactory description of “mental health,” let alone of an ideal state anyone should be shooting for. Levine is in good company, of course, and he appropriately cites Szasz, Fromm, Krishnamurti, Aldous Huxley, R.D. Laing and others who share that view. “Only a profoundly uncritical thinker would celebrate adjustment in of itself without a critical analysis of what one is adjusting to” Levine writes. That is true, but there is an underlying history to the whole idea of “adjustment” which also helps explain why psychiatry so thoroughly espouses the whole biological view of man, including the “chemical imbalance” theory. Adjustment is an idea born in the Darwinian biological theory of evolution. As such, it might effectively explain how one animal species after another came to survive longer and more robustly by “adjusting” to the threatening aspects of their environment. Adjustment is a concept that is pertinent to the field of evolutionary biology. Adjustment, however, is not a concept that is the least bit pertinent to the ideal emotional and mental state of a human being. Adjustment is only pertinent for animals. Man has been successful not by adjusting to his environment, but by conquering it. Man is a composite identity of spirit, mind, and body, and it is the spirit that provides an individual human with the life force that conquers, overcomes, or out-creates adversity in his environment. Only animals “adjust” in order to survive. Psychiatry’s claim that adjustment is an ideal state for human mental health shows how poorly they think of man. Seeing only an animal nature in man also allows them to perform electroconvulsive therapy and chemical lobotomies with this utterly misguided “animal” justification. Zapping somebody with 450 volts of electricity or turning them into a zombie with a cocktail of Xanax, Paxil, and Risperdal comes from the same theory of approach a veterinarian uses to put a dog out of his misery by euthanizing him. Psychiatry euthanizes the human spirit. They use the physical force of ECT and psychotropic medication to control humans, just as if they were trying to housetrain a puppy by continually beating his behind with the harsh blows of a newspaper every time he “makes a mistake.” Behavioral conditioning and adjustment are nineteenth century ideas about how to make animals behave as we want them to. They have no place in any field of true help from human therapy.

Articles, Blog posts

Far More Youth Now Prescribed Dangerous Psychotropic Cocktails

Far More Youth Now Prescribed Dangerous Psychotropic Cocktails February 18, 2026 – Robert Carter Last week the Perelman School of Medicine at the University of Pennsylvania published findings that one out of every four young people taking psychotropic medications is taking them as part of a dangerous cocktail of medications which can lead to “serious drug interactions.” “Interactions” like those of Jesse Van Rootselaar? She killed five others and herself the week before in Tumbler Ridge, British Columbia, after taking what she said were several different kinds of prescription antidepressants and antipsychotic drugs after spending time in a psych ward. The Perelman study, published in the Journal of the American Academy of Child and Adolescent Psychiatry found that psychotropic medication prescriptions increased from just over five percent to just over eight percent of the population from 2001 to 2020. The greatest increase was among children 6 to 11 years old and young adults 20 to 24 years old. The use of stimulant medications for ADHD, which have the most severe Black Box warning for risk of violence to self and others, almost doubled during that same time period from 2.7 to 5.4 percent. During he same time, the number of youth taking more than one of those dangerous medications doubled. One quarter of the youth surveyed were taking multiple medications that have the potential to cause serious harm when combined. These cocktails “require close monitoring, dose adjustment, or avoidance in the first place,” the article notes. The researchers said that half of those youth taking antipsychotic medications were at risk of a “potentially dangerous major interaction” as a result of taking another medicine. In fact, just under half of those youth taking antidepressants had already had at least “one major interaction.” As in the “one major interaction” Jesse Van Rootselaar had with those five Tumbler Ridge residents she murdered. Is it really only a coincidence that the increase in mass shootings in America over the last two decades parallels the statistical rise in the number of our youth who have now become part of these “major interaction” minefields? At least RFK, Jr. thinks it’s worth investigating.

Articles, Blog posts

Suicidal Empathy and Big Pharma Funding

Suicidal Empathy and Big Pharma Funding February 13, 2026 – Robert Carter With the 1987 FDA approval of Prozac, Big Pharma launched a relentless marketing campaign for their breakthrough miracle SSRI that would solve anyone’s emotional distress. TV ads, magazine ads, doctor’s office white papers, and seminars all over the place were used to promote the wonders of Prozac and other new psychiatric drugs. Prozac was everywhere, even on the cover of Time magazine. Now Big Pharma just needed more customers so they could really make some money off this thing. A much more covert marketing campaign was put into place to convince Americans just how many of us were mentally ill. Questionnaires were suddenly being filled out at every general practitioner’s office visit and at every pediatrician’s office around the country. Articles then began appearing by prominent academics touting the epidemic of mental illness in the country. Politicians were soon persuaded – by healthy campaign donations: Biden alone received $9 million from Big Pharma – to introduce legislation that would fund treatment for all these poor souls who suddenly had been discovered and who now needed mental help. Remember: community surveys done in the 1930s and 1940s showed that less than one in a thousand Americans experienced any depression, per Charlotte Silverman’s 1968 book, The Epidemiology of Depression. And that was during the time of two world wars and one Great Depression. Today Big Pharma’s underground marketing team is putting out into the public and government eye the fact that there are now too few psychiatric beds in America which can be used to house this growing population of mentally ill. It would be cruel – no…it is now already cruel – not to be doing something to help these poor souls. So, there is now a bill before the U.S. Congress that would eliminate the exclusion of psychiatric hospitals from receiving Medicaid payments and increase the age range of patients there eligible for them. The Treatment Advocacy Center and the National Alliance on Mental Illness (predominantly funded by big Pharma) are lobbying heavily for its passage. It turns out, however, that only the number of government-owned psychiatric beds has declined — from 64 percent to 48 percent — from 2011 to 2023. The number of independent psychiatric facility beds, owned by for-profit chains, has grown 27 percent in that same time period. Those are the beds that the removal of the Medicaid payment exclusion bill would now let the government to fund. Surprise, surprise. Gad Saad’s “suicidal empathy” has a new application here. By convincing politicians to increase funding for the “mentally ill,” a whole new population of the innocent and vulnerable can be made a highly profitable market for Big Pharma and for private psychiatric facilities. This suicidal empathy will have the exact opposite effect empathy is supposed to have. Another population will be added to those 43,000,000 millions now taking antidepressants even though they don’t really need them, but who cannot easily wean themselves from.

Articles, Blog posts

Big Pharma Bottom Feeders’ Gold Rush Greed

Big Pharma Bottom Feeders’ Gold Rush Greed      By Robert Carter/January 31, 2026      Big Pharma remains one of the most profitable industries on the planet with an annual net income profit of almost 14 percent. That’s almost twice the profit margin in other major industries. Pharmaceutical companies have more than enough money to spread around, even for their funding of 75 percent of the FDA’s pharmaceutical division.      You ask, isn’t there an ethical conflict of interest there for the FDA? Probably…but when there’s that much money spilling over the top of those high profit margins, it’s easy for a kind of gold rush mentality to take over from any ethical considerations.      A recent court case has brought to light a small pocket of some bottom feeders for Big Pharma wealth which have appeared in the Miami area. Dubbed “contract research organizations,” these carpetbagger clinical trial conductors are hired by pharmaceutical companies and private investors to do the research for prospective drugs so they can be approved by the FDA and introduced to the market.      In July, 2025, drug developer T3D Therapeutics filed a legal complaint against the contract research organization they had hired to do research on a prospective drug that stimulates the brain’s ability to process sugar and thereby reduce cognitive decline in Alzheimer’s patients.      Of course, that T3D idea was based on the chemical imbalance theory that has been so thoroughly debunked since Big Pharma began marketing it back in the 1980s.      In any case, when T3D began examining the results from the $35 million trial, underwritten by private and government funding, they discovered a “medically impossible” collection of unusable data that was virtually all fraudulent. Clinilabs had been hired to manage the five Miami area clinics doing the research, but these for-profit firms had been using unqualified trial participants as well as using questionable clinical trial protocol. Some of their reported positive results were simply outright lies.      Trial sites like these in Miami have been involved in more than 11,000 trials. South Florida has become a lucrative area for the $85 billion contract research business because of the high average age of its residents, which appeals to drug manufacturers. Older trial participants are apparently more easily recruited with the high fees paid, the lavish food provided them, and the “cognitive difficulties” they might claim which are so easy to fake.      In fact, a small community of “professional patients” has sprung up in Miami and elsewhere to reap the financial rewards available. Many of them have been found to just covertly dump the experimental pills they are supposed to take rather than risk any potentially dangerous side effects from them.      Gold rush ethics beget gold rush ethics all the way down the line. So, how trustworthy are the results of any of the thousands and thousands of these new drug trials that are being done?      The only thing trustworthy is the accuracy of the ledger entries for the millions being invested and then being pocketed by these gold rush, bottom feeder, contracted research organizations.

Articles, Blog posts

Psychiatrists Not Good People with Positive Intentions

Psychiatrists: Not “Good People with Positive Intentions” By Robert Carter/January 27, 2026 Psychiatrist Richard Moldawsky’s blog that was published today on the Mad in America website offers a horrifying peek into the mind of a psychiatrist. It also shows why psychiatry is unable to take any responsibility for its damage to humanity. Entitled “Groupthink in Mainstream and Critical Psychiatry,” Moldawsky’s article contains two sentences that reveal far more than the author ever intended about the underpinnings of psychiatric thought. After acknowledging the presence of “groupthink” in today’s psychiatric community, the author goes on to say that “groupthink” is also present in the critical psychiatry movement. It therefore clouds the objective clarity of each group. Possibly so. Then he writes “Groupthink just happens…” It “just happens”? Where is the scientific mind in that pronouncement? You know, the inquiring, objective analysis of facts that seeks to isolate true cause and effect in order to put a solution into effect. Although Moldawsky seems aware that the term groupthink was made popular by social psychologist Irving Janis in 1972, he seems unaware that the term was coined by William H. Whyte in 1952 and was based on the “doublethink” and “crimethink” of George Orwell’s novel 1984. Both terms describe the force a totalitarian party uses to make citizens accept contradictory beliefs as truth (for instance, “War is peace”). Not unlike, ironically, Moldawsky’s attempt to have his readers see the identity between the pro- and anti-psychiatry groups because of their mutual “groupthink.” The other sentence, which is even more horrifying , is this: “Ethics is not the sole purview of medicine.” Really? What about the Hippocratic Oath? Isn’t “doing no harm and acting in a patient’s best interest” the cornerstone of Western medicine and the “sole purview” upon which any medical practice should be based? At a recent Inner Compass seminar, therapist Dr. Roger McFillin said about conventional therapy (including psychiatry) harming people: “I don’t think it’s an accident. I don’t think it’s good people with positive intentions. If you follow the “rules,” your clients will get worse.” If groupthink “just happens” – as psychiatrist Moldawsky proclaims – and if ethical practice is not the first order of business in therapy, then psychiatrists do not have to be responsible for the damage they do. Thank you, Dr. Moldawsky, for clarifying that today. You provide a perfect example of Dr. McFillin’s condemnation of those men and women who are not “good people with positive intentions.”

Articles, Blog posts

What Do Psychiatrists Consider an Ideal Personality?

What Do Psychiatrists Consider an Ideal Personality?      By Robert Carter/January 17, 2026      In 2022 psychiatrists added “Prolonged Grief Disorder” to their questionable list of mental disorders in the DSM. This new disorder is separate from all your run of the mill DSM depressions, and it can be diagnosed twelve months after someone has lost a loved one. Of course, the remedy to it is a prescription for one of Big Pharma’s emotion-deadening antidepressants.      Prolonged Grief Disorder is hardly the first normal human reaction to life’s ups and downs to be transmogrified into a mental disorder so a prescription can be written for it. Consider “Somatic Symptom Disorder,” which is the mental illness of worrying too much if you’ve been diagnosed with cancer, or “Binge Eating Disorder,” which labels even occasional gluttony as a clinical psychiatric pathology, or “Post-Menstrual Dysphoric Disorder,” which makes a woman’s monthly mood swings a mental disease.      These labels would just seem hysterically asinine if they weren’t used by psychiatry to numb its diagnosed prey with Big Pharma’s dangerous medications. More than 43,000,000 Americans are currently prescribed antidepressants every year.      There’s a flip side to this mania of dark labeling, though. If these normal human responses to life are considered disorders, what picture does that paint of the personality a psychiatrist then must view as ideal. What’s their poster image of an ideal human being?      Someone who does not feel any of the normal ups and downs of life. That’s what they’re shooting for.      Now, here’s what’s really a scream: that describes exactly the personality someone ends up with after they’ve been taking prescribed antidepressants or anti-anxiety pills. That is the psychiatrists’ goal, their “ideal” human being. A numbed, unfeeling robot.      That zombie “ideal” human personality, of course, is the one a psychiatrist already has…with or without medication. Otherwise, how could a psychiatrist destroy so many real human lives with unnecessary medication and not even bat an eye?

Articles, Blog posts

I Am an On-line Mental Health Counselor. I Am a Robot.

I Am an On-line Mental Health Counselor. I Am a Robot.      By Robert Carter/December 1, 2025      A recently published cross-sectional study surveyed a thousand youths and young adults about using on-line AI sites for their mental health issues. 13 percent of all the participants had asked AI chatbots for mental health advice, but a full 22 percent of the 18-21 year old participants had consulted AI about their mental health concerns.      92 percent of them felt that they had received helpful advice from the AI chatbot. 65 percent of them sought AI advice at least once a month, and 10 percent of the 18-12 year olds contacted AI for that purpose almost daily.      That percentage of youth using AI for consultation about their own mental health translates into 5.4 million young Americans.      The survey was conducted by RAND, Harvard, Brown, Mass General Brigham, and Boston Children’s Hospital and the results were published in the JAMA Network Open. The surveyors initially contacted just over two thousand young people and half responded, almost exactly half of them female and half male.        The researchers only speculate on some of the various cultural anomalies revealed by the study – such as the low percentage of Blacks who seek online mental health advice – and Peter Simons, who reported on the study at Mad in America, noted the dangers from artificially created advice paradigms that can encourage delusional thinking about mental health and can even encourage suicidal thinking in their on-line clients.      Those are not the largest red flags from the study, however.      How is that one out of every five 18-21 year olds in this country has taken it into his or her young head that they have a mental health issue of such magnitude that they feel compelled to seek advice so often from an AI chatbot?      Either there really are that many mentally ill youth in the country, or there are that many youth in the country who have been brainwashed into believing that they might be mentally ill.      Psychiatry and Big Pharma continue to publicly promote a high number of mentally unhealthy Americans. Forty percent is their most popular PR figure. That number, however, is a compilation of the results of the ubiquitous mental health questionnaires they have introduced into schools, doctors’ offices, and hospitals for people to innocently take.      Those initial mental health screening tools like the Patient Health Questionnaire-9 (PHQ-9) for depression and the Generalized Anxiety Disorder-7 (GAD-7) are proven to result in a high number of “false positive” responses because of the low specificity of their questions as wells as their cultural, demographic and gender inconsistencies.      Both are perfect examples of what can be achieved with “leading questions.” From them, a person with a temporary upset over a deceased pet or an argument with a parent can be claimed by psychiatry to have a mental health issue.      Does that mean that forty percent of all Americans might have had a recent upset in life? Probably. Does that also mean that forty percent of all Americans have a mental health issue requiring some form of treatment…preferably pharmacological, of course, to help fill Big Pharma’s coffers? Probably not.      Big Pharma uses its forty percent number to lobby for large increases in  government funded mental health treatment in this country for those without private insurance. As many as 35 percent of foster children are on at least one psychotropic medication, and in residential treatment centers or group homes half of those foster children are on psychiatric medication, paid for by the government (aka, by us taxpayers).      It’s bad enough that our government has been convinced to increase funding for mental health treatment because of these falsely inflated numbers of Americans with mental health problems. It’s far worse that Big Pharma’s insidious marketing of what constitutes “mental illness” has now apparently successfully brainwashed one out of every five of our 18-21 year olds.      These unfortunate, now robotic thinking youth are today consulting with on-line robots to form a new, perfectly thoughtless and perfectly automatic money making machine for Big Pharma.

Articles, Blog posts

Psychiatry “Disappears” Anti drug Advocate Loren Mosher

Psychiatry “Disappears” Anti-drug Advocate, Loren Mosher      By Robert Carter/November 20, 2025      American Psychiatrist Loren Mosher followed a prestigious route for his training in mental health, receiving degrees from both Stanford and Harvard, and he began working at the National Institute of Mental Health in 1964. He soon developed an interest in alternative treatments for schizophrenia.      In 1968 he was promoted to the role of Director for the NIMH Center for Schizophrenia Studies. He soon formed the view that the controlling atmosphere of a psychiatric hospital and the over-medication of schizophrenic patients actually hindered their recovery.      Mosher then started the Soteria Research Project in San Jose, California, in 1971. He selected unmarried patients between the ages of 18 and 30 who had been diagnosed with schizophrenia, per the DSM-II label. The staff were trained to treat the residents as equals in a calm, non-institutional environment and the residents participated equally with staff in running the house. Medication was kept to a minimum.      At the end of the first two years , 42 percent of the residents had never been exposed to antipsychotics. 39 percent had used medication for a shorter period of time. Only 19 percent had taken them continually. The Soteria patients had lower psychopathology scores, had fewer hospital readmissions, and had better global adjustment compared to conventionally institutionalized patients treated with antipsychotic medication.      The San Jose Soteria project ran for ten years until 1983, when its funding was denied by an increasingly Big Pharma controlled psychiatric community.      In 1980 Loren Mosher himself was fired from his position as head of the Schizophrenia Center at the NIMH. Big Pharma’s psychiatric establishment could no longer tolerate his views on what constituted successful treatment for schizophrenia. In 1988 he resigned publicly from the American Psychiatric Association by writing that his true belief was that he was “actually resigning from the American Psychopharmacological Association. Luckily, the organization’s true identity requires no change in the acronym.”      Today in America, psychiatry remains under Big Pharma’s stranglehold philosophy of overmedication and controlled institutionalization.      Overseas, successful Soteria-based treatment facilities still operate today in Sweden, Finland, Germany, Switzerland, and Hungary. There is only one Soteria-based treatment facility in America, in South Burlington, Vermont.      Mosher held various teaching positions after being ostracized by the officialdom of psychiatry, and he worked closely until his death in 2024 with patient advocacy groups such as Mind Freedom International to protect the rights of people who have been labeled with psychiatric disorders .

Scroll to Top